The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Overweight
In brief
The purpose of this study is to determine if the drug orlistat (Alli, Xenical) decreases the taste for fat in humans.
Key facts
- Study ID
- NCT01719419
- Run by
- Pennington Biomedical Research Center
- People needed
- 0
- Starts
- 2012-03-01
- Expected to finish
- 2012-09-01
- Last updated by the study team
- 2015-12-18
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Are a healthy male or female,
- Are between 18 to 70 years of age,
- Have a body mass index between 25-35 kg/m2
You may not qualify if…
- Are a female who is pregnant or nursing,
- Are a restrained eater (determined using a questionnaire),
- Have any current illnesses such as an infection,
- Have any serious medical problems including kidney, liver, heart or lung disease,
- Use medications known to increase appetite,
- Are taking any medication that has not been on the same dose for at least 30 days,
- Dislike the test food.
Where it is running
- Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.